Vimarsana
Biggest News Aggregation in the World

Page 3 - Immunotherapy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunotherapy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunotherapy Program Today - Breaking & Trending Today

Can probiotics protect us from cancer? Pitt researchers find clues studying mice - Vimarsana News

Can probiotics protect us from cancer? Pitt researchers find clues studying mice

A new study from a team of University of Pittsburgh researchers offers further evidence about the importance of good gut health.

World-Renowned Myeloma Expert, Dr. Ivan Borrello, Joins TGH Cancer Institute to Lead Its Bone Marrow Transplant (BMT)and Cell Therapies Program - Vimarsana News

World-Renowned Myeloma Expert, Dr. Ivan Borrello, Joins TGH Cancer Institute to Lead Its Bone Marrow Transplant (BMT)and Cell Therapies Program

/PRNewswire/ -- Tampa General Hospital is announcing its appointment of Dr. Ivan Borrello to the TGH Cancer Institute. Borrello is a world-class translational...

Eating fiber alters the microbiome. It may help in cancer fight, too. - Vimarsana News

Eating fiber alters the microbiome. It may help in cancer fight, too.

Scientists believe that giving patients a fiber-rich diet of fruits, vegetables, beans, nuts and whole grains to nourish the gut microbiome might improve the odds that the cancer treatment immunotherapy is effective.

Cancer researchers test fiber-rich diet to improve immunotherapy results - Vimarsana News

Cancer researchers test fiber-rich diet to improve immunotherapy results

Cancer researchers think they have found one explanation for why some cancer drugs don't always work.

Research finds immune system responds to mRNA treatment for cancer - Vimarsana News

Research finds immune system responds to mRNA treatment for cancer

Adding messenger RNA, or mRNA therapy improves the response to cancer immunotherapy in patients who weren’t responding to the treatment, Mayo Clinic